Viral burden is associated with age, vaccination, and viral variant in a population-representative study of SARS-CoV-2 that accounts for time-since-infection-related sampling bias
Year: 2023
Type: article
Abstract: In this study, we evaluated the impact of viral variant, in addition to other variables, on within-host viral burden, by analysing cycle threshold (Ct) values derived from nose and throat swabs, collected as part of the UK COVID-19 Infection Survey. Because viral burden distributions determined from community survey data can be biased due to the impact of variant epidemiology on the time-since-infection of samples, we developed a method to explicitly adjust observed Ct value distributions to account for the expected bias. By analysing the adjusted Ct values using partial least squares regression, we found that among unvaccinated individuals with no known prior exposure, viral burden was 44% lower among Alpha variant infections, compared to those with the predecessor strain, B.1.177. Vaccination reduced viral burden by 67%, and among vaccinated individuals, viral burden was 286% higher among Delta variant, compared to Alpha variant, infections. In addition, viral burden increased by 17% for every 10-year age increment of the infected individual. In summary, within-host viral burden increases with age, is reduced by vaccination, and is influenced by the interplay of vaccination status and viral variant.
Source: PLoS Pathogens
Authors: Helen R. Fryer, Tanya Golubchik, Matthew Hall, Christophe Fraser, Robert Hinch, Luca Ferretti, Laura Thomson, Anel Nurtay, Lorenzo Pellis, Thomas House, George MacIntyre-Cockett, Amy Trebes, David Buck, Paolo Piazza, Angie Green, Lorne J Lonie, Darren Smith, Matthew Bashton, Matthew Crown, Andrew Nelson, Clare M. McCann, Mohammed Adnan Tariq, Claire J. Elstob, Rui Nunes Dos Santos, Zack Richards, Xin Xhang, Joseph Hawley, Mark R. Lee, Priscilla Carrillo-Barragan, Isobel Chapman, Sarah Harthern-Flint, David Bonsall, Katrina A. Lythgoe
Language: English
Subfield: Infectious Diseases
Field: Medicine
Domain: Health Sciences
Open Access status: gold
Estimated APC paid: $2,705
Funders: Bill and Melinda Gates Foundation, Li Ka Shing Foundation, Northumbria University, Wellcome Trust, Alan Turing Institute, UK Research and Innovation, National Institute for Health and Care Research, Department of Health and Social Care, Royal Society, University of Sydney, Medical Research Council, Engineering and Physical Sciences Research Council, Research England, Medical Research Foundation
Awards: Human Genetics and Disease Biology: Core Renewal for the Wellcome Trust Centre for Human Genetics, G1329953243, G1430171571, G1633672591, G1650259125, University of Oxford - to develop sensitive methods for characterizing HIV infection and transmission, G2411624253, From molecules to pandemics: multi-level adaptation of human chronic viruses., G3855435662, G386625891, The Alan Turing Institute, G5322103689, G5918494183, G5984896815, G6585126884, G6868616705, Human Genetics and Disease Biology: Core Renewal for the Wellcome Trust Centre for Human Genetics, G8209214693, COVID-19 Modelling Consortium: quantitative epidemiological predictions in response to an evolving pandemic, G8597009950, Epidemiological and evolutionary consequences of coinfection: a multi-scale modelling approach, G8635116759, G8960917998
OpenAlex ID: W4385802000
